These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20586664)

  • 1. Analysis of gelatin plasma substitutes in blood based on detection of hydroxyproline derivatives.
    Liu T; Zhanga G; Li S; Wang Y; Ma G; Su Z
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Feb; 39(1):19-25. PubMed ID: 20586664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal function, blood volume reaction and hemostatic changes after an infusion of a plasma substitute with a gelatin base].
    Pflueger H
    Rev Bras Anestesiol; 1969; 19(2):260-70. PubMed ID: 5352461
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on the temporal change of properties of genipin crosslinked gelatin].
    Jin X; Yan J; Zhou L; Ji Y; Yang X; Xu G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Feb; 25(1):150-3. PubMed ID: 18435279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pulse-released nerve growth factor from genipin-crosslinked gelatin in schwann cell-seeded polycaprolactone conduits on large-gap peripheral nerve regeneration.
    Chang CJ
    Tissue Eng Part A; 2009 Mar; 15(3):547-57. PubMed ID: 18925830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic plasma volume expanders--their pharmacology, safety and clinical efficacy.
    Mishler JM
    Clin Haematol; 1984 Feb; 13(1):75-92. PubMed ID: 6202449
    [No Abstract]   [Full Text] [Related]  

  • 6. Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin.
    Yao CH; Liu BS; Hsu SH; Chen YS; Tsai CC
    J Biomed Mater Res A; 2004 Jun; 69(4):709-17. PubMed ID: 15162413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified fluid gelatin in leukapheresis accumulation and persistence in the body.
    Rock G; Wise P; Kardish R; Huestis DW
    Transfusion; 1984; 24(1):68-73. PubMed ID: 6695441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in blood volume and plasma proteins after trauma and immediate substitution with different substitutes.
    Rieger A
    Bibl Haematol; 1969; 33():159-70. PubMed ID: 5377190
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of cross-linking degree of a biodegradable genipin-cross-linked gelatin guide on peripheral nerve regeneration.
    Lu MC; Hsiang SW; Lai TY; Yao CH; Lin LY; Chen YS
    J Biomater Sci Polym Ed; 2007; 18(7):843-63. PubMed ID: 17688744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on the velocity of the elimination of plasma substitutes from the blood stream in rabbits.
    Nitschmann H; Stoll HR
    Bibl Haematol; 1969; 33():152-8. PubMed ID: 5383988
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation of genipin cross-linked chitosan-gelatin microcapsules for encapsulation of Zanthoxylum limonella oil (ZLO) using salting-out method.
    Hussain MR; Maji TK
    J Microencapsul; 2008 Sep; 25(6):414-20. PubMed ID: 18465294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on modified fluid gelatin as a serum volume expander].
    Murakami S; Hamabe N; Kitani M; Ota Y; Tanigawa H
    Masui; 1969 Jun; 18(6):500-9. PubMed ID: 5816994
    [No Abstract]   [Full Text] [Related]  

  • 13. [HES, dextran and gelatin--indications and tolerance].
    Laubenthal H; Sirtl C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Apr; 33(4):251-5. PubMed ID: 9617425
    [No Abstract]   [Full Text] [Related]  

  • 14. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration: in vitro and in vivo studies.
    Liang HC; Chang WH; Lin KJ; Sung HW
    J Biomed Mater Res A; 2003 May; 65(2):271-82. PubMed ID: 12734822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of genipin degradation in aqueous solution.
    Slusarewicz P; Zhu K; Hedman T
    Nat Prod Commun; 2010 Dec; 5(12):1853-8. PubMed ID: 21299106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacodynamics of plasma substitutes].
    Mas Marfany J
    Rev Esp Anestesiol Reanim; 1971 Jan; 18(1):108-14. PubMed ID: 5552978
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface modification of poly(ε-caprolactone) porous scaffolds using gelatin hydrogel as the tracheal replacement.
    Lin CH; Hsu SH; Su JM; Chen CW
    J Tissue Eng Regen Med; 2011 Feb; 5(2):156-62. PubMed ID: 20662011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on modified fluid gelatin as a plasma substitute (2)].
    Tosaki Y; Shirai T; Taori M
    Masui; 1969 Oct; 18(10):932-41. PubMed ID: 5390132
    [No Abstract]   [Full Text] [Related]  

  • 20. Calvarial bone response to a tricalcium phosphate-genipin crosslinked gelatin composite.
    Yao CH; Liu BS; Hsu SH; Chen YS
    Biomaterials; 2005 Jun; 26(16):3065-74. PubMed ID: 15603801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.